TABLE 1.
Sample type | Cmax (ng/ml)b | Tmax (days)c | AUCt-last (days · ng/ml)d | MRTC-last (days)e |
---|---|---|---|---|
Plasma | ||||
AFX | 196 ± 160.2 | 0.4 ± 0.4 | 1,217.5 ± 751.5 | 7.1 ± 2.4 |
IVM | 44.2 ± 11.6f | 0.2 ± 0.0 | 38.7 ± 17.9 | 1.1 ± 0.2f |
Skin | ||||
AFX | 1,909.2 ± 962.4 | 1.25 ± 0.5 | 11,159.3 ± 6,158.4 | 16.2 ± 16.9 |
IVM | 72.0 ± 40.2f | 1.0 ± 0.0 | 186.2 ± 104.8 | 2.7 ± 0.5f |
Values are presented as means ± SDs of AFX and IVM in the plasma and in the skin of pigs following oral intake.
Cmax, maximum plasma concentration.
Tmax, time to maximum plasma concentration.
AUCt-last, area under the plasma curve concentration-time curve from time zero after first administration to the last sampling time point with a measurable concentration.
MRTC-last, mean residence time.
P < 0.001 versus. AFX (compared with a nonparametric Mann-Whitney test).